Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Coherus Oncology, Inc.CHRS · Entity 6276 | Director | February 01, 2018 | February 05, 2018 |
| Medpace Holdings, Inc.MEDP · Entity 3327 | Director · President & CEO · 10% owner | September 29, 2026 | October 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Coherus Oncology, Inc.
Report date February 01, 2018 · Filed February 05, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.05 · Expires 2028-02-01 | Direct | 20,000 |
Reported balance
After 2018-02-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-02-01 · Grant · Acquired 20,000 · Balance 20,000 F3: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. |
| Common Stock, $0.0001 par valueSEC Table I · non-derivative | Direct | 29,994 |
Reported balance
Holding disclosure · report date 2018-02-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 29,994 |
| Common Stock, $0.0001 par valueSEC Table I · non-derivative | IndirectSee Footnote | 1,642,492 |
Reported balance
Holding disclosure · report date 2018-02-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,642,492 F1: The shares are held by MX II Associates LLC ("MX II Associates"). Reporting Person is the Managing Member of MX II Associates. Voting and dispositive decisions with respect to shares held by MX II Associates are made by Reporting Person, however, Reporting Person disclaims beneficial ownership of the shares held by MX II Associates, except to the extent of any pecuniary interest therein. |
| Common Stock, $0.0001 par valueSEC Table I · non-derivative | IndirectSee Footnote | 268,428 |
Reported balance
Holding disclosure · report date 2018-02-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 268,428 F2: The shares are held by Medpace Investors, LLC ("Medpace Investors"). Reporting Person is the Manager of Medpace Investors. Voting and dispositive decisions with respect to shares held by Medpace Investors are made by Reporting Person, however, Reporting Person disclaims beneficial ownership of the shares held by Medpace Investors, except to the extent of any pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares are held by MX II Associates LLC ("MX II Associates"). Reporting Person is the Managing Member of MX II Associates. Voting and dispositive decisions with respect to shares held by MX II Associates are made by Reporting Person, however, Reporting Person disclaims beneficial ownership of the shares held by MX II Associates, except to the extent of any pecuniary interest therein.
F2: The shares are held by Medpace Investors, LLC ("Medpace Investors"). Reporting Person is the Manager of Medpace Investors. Voting and dispositive decisions with respect to shares held by Medpace Investors are made by Reporting Person, however, Reporting Person disclaims beneficial ownership of the shares held by Medpace Investors, except to the extent of any pecuniary interest therein.
F3: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Medpace Holdings, Inc.
Report date September 29, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 338,225 |
Ending reported balance
After 2026-09-30 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-29 · Sale · Disposed 26,701 · Balance 360,191 F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $622.35. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Row 2 · 2026-09-30 · Sale · Disposed 21,966 · Balance 338,225 F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.105 to $628.08. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| Common StockSEC Table I · non-derivative | IndirectBy Medpace Investors, LLC | 4,733,019 |
Reported balance
Holding disclosure · report date 2026-09-29 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,733,019 F4: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $622.35. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.105 to $628.08. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F4: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 05, 2020 Filed Aug 6, 2020 20:55 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 13,179 | $125.04 | $1,647,902.16 |
DisclosureSEC source: 0001567619-20-014435 · doc1.xml · nonDerivative · entry 3 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,112,203 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $123.48 to $125.905. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:55 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 45,488 | $124.43 | $5,660,071.84 |
DisclosureSEC source: 0001567619-20-014435 · doc1.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,125,382 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $123.12 to $126.605. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 27,005 | $124.13 | $3,352,130.65 |
DisclosureSEC source: 0001567619-20-014144 · doc1.xml · nonDerivative · entry 3 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,170,870 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $120.485 to $125.76. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 39,622 | $118.17 | $4,682,131.74 |
DisclosureSEC source: 0001567619-20-014144 · doc1.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,197,875 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $116.665 to $119.97. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 30, 2020 Filed Jul 31, 2020 20:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 42,955 | $120.79 | $5,188,534.45 |
DisclosureSEC source: 0001567619-20-013981 · doc1.xml · nonDerivative · entry 3 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,237,497 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $118.495 to $124.015. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 20:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 47,106 | $123.99 | $5,840,672.94 |
DisclosureSEC source: 0001567619-20-013981 · doc1.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,280,452 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $120.925 to $125.405. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 28, 2020 Filed Jul 29, 2020 20:14 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 214,499 | $127.23 | $27,290,707.77 |
DisclosureSEC source: 0001567619-20-013885 · doc1.xml · nonDerivative · entry 3 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,327,558 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $116.765 to $143.965. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 20:14 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 29,019 | $110.43 | $3,204,568.17 |
DisclosureSEC source: 0001567619-20-013885 · doc1.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,542,057 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $106.69 to $112.55. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 24, 2020 Filed Jul 27, 2020 20:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 34,380 | $106.13 | $3,648,749.40 |
DisclosureSEC source: 0001567619-20-013760 · doc1.xml · nonDerivative · entry 3 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,571,076 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $105.41 to $110.04. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 20:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 31,743 | $111.83 | $3,549,819.69 |
DisclosureSEC source: 0001567619-20-013760 · doc1.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,605,456 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $109.82 to $114.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:23 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 35,878 | $109.99 | $3,946,221.22 |
DisclosureSEC source: 0001567619-20-013639 · doc1.xml · nonDerivative · entry 3 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,637,199 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $106.89 to $111.26. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:23 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 28,090 | $106.78 | $2,999,450.20 |
DisclosureSEC source: 0001567619-20-013639 · doc1.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,673,077 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $105.32 to $107.74. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 20, 2020 Filed Jul 21, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 17,735 | $105.47 | $1,870,510.45 |
DisclosureSEC source: 0001567619-20-013530 · doc1.xml · nonDerivative · entry 3 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,701,167 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $104.385 to $106.345. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 19,309 | $105.32 | $2,033,623.88 |
DisclosureSEC source: 0001567619-20-013530 · doc1.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,718,902 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $103.43 to $106.14. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 16, 2020 Filed Jul 17, 2020 20:13 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 15,273 | $103.70 | $1,583,810.10 |
DisclosureSEC source: 0001567619-20-013425 · doc1.xml · nonDerivative · entry 3 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,738,211 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $103.16 to $105. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 20:13 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 28,700 | $104.90 | $3,010,630.00 |
DisclosureSEC source: 0001567619-20-013425 · doc1.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,753,484 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $101.48 to $106.305. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 13, 2020 Filed Jul 13, 2020 20:55 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 6,127 | $100.50 | $615,763.50 |
DisclosureSEC source: 0001567619-20-013219 · doc1.xml · nonDerivative · entry 3 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,782,184 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $100.00 to $101.215. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 20:55 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 2,455 | $100.15 | $245,868.25 |
DisclosureSEC source: 0001567619-20-013219 · doc1.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,788,311 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $100.00 to $100.56. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:54 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,518 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0000899243-20-012420 · doc4.xml · derivative · entry 3 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 93,969 Underlying: Common Stock · 3,518 shares Expires 2021-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:54 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 3,518 | $14.41 | $50,694.38 |
DisclosureSEC source: 0000899243-20-012420 · doc4.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,790,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:54 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 84,770 | $0.00 Strike: $107.93 | $0.00 |
DisclosureSEC source: 0001567619-20-005475 · doc1.xml · derivative · entry 3 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,770 Underlying: Common Stock · 84,770 shares Expires 2026-02-28 F2 · derivative.exercise_date: The option vests immediately upon issuance. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:54 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantCommon Stock | 12,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-005475 · doc1.xml · nonDerivative · entry 1 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 616,643 Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,962 | $0.00 Strike: $16.20 | $0.00 |
DisclosureSEC source: 0001567619-20-002090 · doc1.xml · derivative · entry 8 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 67,897 Underlying: Common Stock · 2,962 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,888 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-20-002090 · doc1.xml · derivative · entry 7 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 5,925 Underlying: Common Stock · 8,888 shares Expires 2021-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 14,814 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-20-002090 · doc1.xml · derivative · entry 6 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 97,487 Underlying: Common Stock · 14,814 shares Expires 2021-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 2,962 | $16.20 | $47,984.40 |
DisclosureSEC source: 0001567619-20-002090 · doc1.xml · nonDerivative · entry 4 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,787,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 8,888 | $14.41 | $128,076.08 |
DisclosureSEC source: 0001567619-20-002090 · doc1.xml · nonDerivative · entry 3 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,784,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 14,814 | $14.41 | $213,469.74 |
DisclosureSEC source: 0001567619-20-002090 · doc1.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,775,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 21:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 555 | $0.00 Strike: $16.20 | $0.00 |
DisclosureSEC source: 0001567619-19-021864 · doc1.xml · derivative · entry 6 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 70,859 Underlying: Common Stock · 555 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 21:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 518 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-19-021864 · doc1.xml · derivative · entry 5 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 112,301 Underlying: Common Stock · 518 shares Expires 2021-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 21:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 555 | $16.20 | $8,991.00 |
DisclosureSEC source: 0001567619-19-021864 · doc1.xml · nonDerivative · entry 3 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,760,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 21:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 518 | $14.41 | $7,464.38 |
DisclosureSEC source: 0001567619-19-021864 · doc1.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,760,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 20:24 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,851 | $0.00 Strike: $16.20 | $0.00 |
DisclosureSEC source: 0001567619-19-018796 · doc1.xml · derivative · entry 8 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 71,414 Underlying: Common Stock · 1,851 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 20:24 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,222 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-19-018796 · doc1.xml · derivative · entry 7 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 14,813 Underlying: Common Stock · 2,222 shares Expires 2021-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 20:24 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,313 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-19-018796 · doc1.xml · derivative · entry 6 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 112,819 Underlying: Common Stock · 4,313 shares Expires 2021-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 20:24 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 1,851 | $16.20 | $29,986.20 |
DisclosureSEC source: 0001567619-19-018796 · doc1.xml · nonDerivative · entry 4 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,759,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 20:24 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 2,222 | $14.41 | $32,019.02 |
DisclosureSEC source: 0001567619-19-018796 · doc1.xml · nonDerivative · entry 3 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,757,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 20:24 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 4,313 | $14.41 | $62,150.33 |
DisclosureSEC source: 0001567619-19-018796 · doc1.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,755,438 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 24, 2019 Filed Nov 19, 2019 21:10 UTC Amendment | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,851 | $0.00 Strike: $16.20 | $0.00 |
DisclosureSEC source: 0001567619-19-021854 · doc1.xml · derivative · entry 6 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 71,414 Underlying: Common Stock · 1,851 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Correction due to administrative error. F3 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 24, 2019 Filed Nov 19, 2019 21:10 UTC Amendment | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,222 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-19-021854 · doc1.xml · derivative · entry 5 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 14,813 Underlying: Common Stock · 2,222 shares Expires 2021-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Correction due to administrative error. F3 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 24, 2019 Filed Nov 19, 2019 21:10 UTC Amendment | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,313 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-19-021854 · doc1.xml · derivative · entry 4 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 112,819 Underlying: Common Stock · 4,313 shares Expires 2021-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Correction due to administrative error. F3 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 20:53 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | PurchaseEmployee Stock Option (Right to Buy) · Derivative | 11,112 | $36.77 Strike: $18.23 | $408,588.24 |
DisclosureSEC source: 0001567619-19-018439 · doc1.xml · derivative · entry 8 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 11,112 Underlying: Common Stock · 11,112 shares Expires 2023-03-31 F2 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. F3 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable. F2 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 20:53 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | PurchaseEmployee Stock Option (Right to Buy) · Derivative | 10,887 | $38.12 Strike: $16.88 | $415,012.44 |
DisclosureSEC source: 0001567619-19-018439 · doc1.xml · derivative · entry 7 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 10,887 Underlying: Common Stock · 10,887 shares Expires 2022-07-31 F2 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. F3 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable. F2 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 20:53 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | PurchaseEmployee Stock Option (Right to Buy) · Derivative | 73,265 | $38.80 Strike: $16.20 | $2,842,682.00 |
DisclosureSEC source: 0001567619-19-018439 · doc1.xml · derivative · entry 6 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 73,265 Underlying: Common Stock · 73,265 shares Expires 2022-03-31 F2 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. F3 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable. F2 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 20:53 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | PurchaseEmployee Stock Option (Right to Buy) · Derivative | 17,035 | $40.59 Strike: $14.41 | $691,450.65 |
DisclosureSEC source: 0001567619-19-018439 · doc1.xml · derivative · entry 5 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 17,035 Underlying: Common Stock · 17,035 shares Expires 2021-07-07 F2 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. F3 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable. F2 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 20:53 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | PurchaseEmployee Stock Option (Right to Buy) · Derivative | 117,132 | $40.59 Strike: $14.41 | $4,754,387.88 |
DisclosureSEC source: 0001567619-19-018439 · doc1.xml · derivative · entry 4 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 117,132 Underlying: Common Stock · 117,132 shares Expires 2021-06-10 F2 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. F3 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable. F2 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 05, 2019 Filed Aug 7, 2019 20:23 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $90.65 | $0.00 |
DisclosureSEC source: 0001567619-19-015936 · doc1.xml · derivative · entry 4 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2024-08-05 F2 · derivative.exercise_date: The option vests immediately upon issuance. Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:33 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 234,259 | $0.00 Strike: $56.61 | $0.00 |
DisclosureSEC source: 0001567619-19-009863 · doc1.xml · derivative · entry 4 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,259 Underlying: Common Stock · 234,259 shares Expires 2026-05-02 F2 · derivative.exercise_date: The option vests immediately upon issuance. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:29 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 77,417 | $0.00 Strike: $54.74 | $0.00 |
DisclosureSEC source: 0001567619-19-006155 · doc1.xml · derivative · entry 4 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,417 Underlying: Common Stock · 77,417 shares Expires 2026-03-01 F2 · derivative.exercise_date: The option vests immediately upon issuance. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 21:28 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 18,920 | $66.54 | $1,258,936.80 |
DisclosureSEC source: 0001567619-19-002372 · doc1.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 7,751,125 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on November 15, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on November 15, 2018. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $66.07 to $67.60. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the shares held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.